Majumder, S., Caccamo, A., Medina, D. X., Benavides, A. D., Javors, M. A., Kraig, E., . . . Oddo, S. (2012). Life-long rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signaling.

Majumder, Smita, Antonella Caccamo, David X. Medina, Adriana D. Benavides, Martin A. Javors, Ellen Kraig, Randy Strong, Arlan Richardson, e Salvatore Oddo. Life-long Rapamycin Administration Ameliorates Age-dependent Cognitive Deficits By Reducing IL-1β and Enhancing NMDA Signaling. 2012.

Majumder, Smita, et al. Life-long Rapamycin Administration Ameliorates Age-dependent Cognitive Deficits By Reducing IL-1β and Enhancing NMDA Signaling. 2012.